All patients older than age 60 years should not undergo a B-type natriuretic peptide screening test.

about

All patients older than age 60 years should not undergo a B-type natriuretic peptide screening test.

Item

http://www.wikidata.org/entity/Q35987037

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

All patients older than age 60 ...... uretic peptide screening test.

@ast

All patients older than age 60 ...... uretic peptide screening test.

@en

type

Item

label

All patients older than age 60 ...... uretic peptide screening test.

@ast

All patients older than age 60 ...... uretic peptide screening test.

@en

prefLabel

All patients older than age 60 ...... uretic peptide screening test.

@ast

All patients older than age 60 ...... uretic peptide screening test.

@en

P1476

All patients older than age 60 ...... uretic peptide screening test.

@en

P2093

Kanu Chatterjee

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening.

The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population.

Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons.

Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study.

Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.

Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism.

Biochemical detection of left-ventricular systolic dysfunction.

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

P304

49-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1541-9215.2004.03376.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15604840

http://www.w3.org/2001/XMLSchema#string